- Telehealth Visits
- Insurance plan information
Frederick Baehner, MD
Anatomic Pathology • Cytopathology- Telehealth Visits
- Insurance plan information
Fine Needle Aspiration Biopsy Mission Bay
Frederick Baehner, MD
Anatomic Pathology • CytopathologyFine Needle Aspiration Biopsy Mission Bay
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Cytopathology, American Board of Pathology
- Anatomic & Clinical Pathology, American Board of Pathology
Residency
- Pathology, University of CA at San Francisco - Pathology GME
Internship
- Pathology, UCSF Medical Center - OMAG
Degree
- MD, University of Kansas School of Medicine
My expertise
Specialties
- Anatomic Pathology
- Cytopathology
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22636%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22636%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.